About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company that is redefining the treatment landscape for central nervous system (CNS) conditions. We are focused on delivering cutting-edge scientific breakthroughs that address critical gaps in patient care. Our innovative product pipeline includes FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine treatments. With several late-stage development programs underway, we aim to tackle a wide array of serious neurological and psychiatric disorders affecting over 150 million individuals across the United States. Together, we are on a mission to address some of the most pressing challenges in brain health, enabling patients and their families to thrive.

